Isomorphic Labs raises $5bn backed by Sequoia and A16z
Read the full story on Sifted.
Read the full story on Sifted.
The average package value nears $300, yet 20% of US adults don’t use security devices to help protect their deliveries due to costs.
Isomorphic Labs, the Alphabet drug discovery company run by Demis Hassabis, has raised $5bn in a Series C round co-led by Greenoaks and Sequoia Capital. The company announced the round on Tuesday, six months after it raised $2.1bn in May.
The first 90 days after a funding round can be overwhelming for founders, but executive coach Kelly Meerbott explains how they can protect their decision-making by pausing before major commitments, acknowledging stress, scheduling candid co-founder conversations, and seeking support from boards and…
In this Q&A, Mike Bellin, a partner and U.S. IPO services leader at PricewaterhouseCoopers, discussed the slowdown in IPO momentum, how public investors are evaluating AI companies, biotech’s resurgence and why SPACs are attracting renewed interest.
Despite calls from some Labour MPs to end the arrangement with Palantir, ministers say a new contract will not be awarded until 2029.
65 active sources
20 Turkish · 45 English
All sources